Clinical Trials Logo
  1. Home
  2. Hyperphagia
  3. NCT02758262
  4. Details
NCT02758262 Clinical Trial

Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite

Hyperphagia Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02758262
Other study ID # 2016-478
Secondary ID
Status Recruiting
Phase N/A
First received April 26, 2016
Last updated March 31, 2017
Start date April 2016
Est. completion date December 2017

Study information
Verified date March 2017
Source Laval University
Contact Christophe Lenglos, PhD
Phone 418-953-9586
Email christophe.lenglos.1@ulaval.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to identify brain mechanisms by which Noninvasive brain stimulation (NIBS) could decrease hyperphagia. The investigators will synchronously deliver NIBS and measure brain activity in a randomized, crossover, sham-controlled, fully blind study. This work will reveal brain mechanisms to reduce hyperphagia and may contribute to new therapeutic avenues to treat this eating disorder.

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date December 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Hyperphagic

Exclusion Criteria:

- Psychiatric disorders

- Pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Noninvasive brain stimulation

Locations
Country Name City State
Canada Centre interdisciplinaire de recherche en réadaptation et intégration sociale Quebec

Sponsors (1)
Lead Sponsor Collaborator
Laval University

Country where clinical trial is conducted

Canada, 

Outcome
Type Measure Description Time frame Safety issue
Primary Food craving assessed by the Food Cravings Questionnaire - State 1 hour
Secondary Brain activity assessed by electroencephalography 1 hour
Secondary Brain activity assessed by blood-oxygen-level dependent contrast imaging 1 hour
See also
  Status Clinical Trial Phase
Completed NCT02629991 - Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Phase 2
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A
Terminated NCT03790865 - Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome Phase 2/Phase 3
Completed NCT03375853 - Computerized Response Training Obesity Treatment N/A
Completed NCT04150991 - Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Recruiting NCT05044000 - Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome N/A
Terminated NCT00175305 - Prader-Willi Syndrome and Appetite Phase 3
Recruiting NCT05200182 - fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating N/A
Completed NCT01863017 - Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome N/A
Recruiting NCT03197662 - Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Phase 2